AF
RVMD icon

Advisornet Financial’s Revolution Medicines RVMD Stock Holding History

Advisornet Financial’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.1K Buy
524
+172
+49% +$25.1K ﹤0.01% 885
2026
Q1 		$34.2K Buy
352
+38
+12% +$3.84K ﹤0.01% 1179
2025
Q4 		$25K Buy
314
+156
+99% +$10.2K ﹤0.01% 1260
2025
Q3 		$7.38K Buy
158
+133
+532% +$5.21K ﹤0.01% 1608
2025
Q2 		$920 Buy
+25
New +$960 ﹤0.01% 1956
2025
Q1 		– Sell
-6
Closed -$262 – 2235
2024
Q4 		$262 Buy
+6
New +$303 ﹤0.01% 1858
2024
Q1 		– Sell
-4
Closed -$115 – 2437
2023
Q4 		$115 Sell
4
-3
-43% -$72 ﹤0.01% 2353
2023
Q3 		$194 Buy
7
+4
+133% +$119 ﹤0.01% 2143
2023
Q2 		$80 Buy
3
+1
+50% +$25 ﹤0.01% 2287
2023
Q1 		$43 Buy
+2
New +$49 ﹤0.01% 2363

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Advisornet Financial's RVMD Position: Q2 2026 in Review

Advisornet Financial increased its Revolution Medicines (RVMD) stake by 49% in Q2 2026, buying an estimated $25.1K and bringing the position to 524 shares worth $98.1K. The position accounts for ﹤0.01% of the portfolio, ranked #885.

Advisornet Financial first reported a position in RVMD in Q1 2023 and has held it in 10 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Advisornet Financial held 524 shares of Revolution Medicines worth $98.1K as of Q2 2026.
  • Advisornet Financial bought 172 Revolution Medicines shares in Q2 2026, an estimated $25.1K.
  • Revolution Medicines made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #885 holding.
  • Advisornet Financial first reported a position in Revolution Medicines in Q1 2023 and has held it in 10 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.